Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents

Immune checkpoint inhibitors have emerged as a mainstay of melanoma therapy and are playing an increasingly important role in the treatment of other tumor types. The clinical benefit afforded by these treatments can be accompanied by a unique spectrum of adverse events, called immune-related adverse...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Weber, Jeffrey S., Postow, Michael, Lao, Christopher D., Schadendorf, Dirk
Format: Artigo
Language:Inglês
Published: AlphaMed Press 2016
Subjects:
Melanoma and Cutaneous Malignancies
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061539/
https://ncbi.nlm.nih.gov/pubmed/27401894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0055
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items